What is the address of MEDICAB?

The registered office of MEDICAB is located at Rue du Bois(PIR) 18, 6240 Farciennes.

Is MEDICAB still active?

Yes. According to the CBE (31 October 2026) MEDICAB is active, legal situation “Normale toestand”, started on 13 August 2008.

Is MEDICAB registered on Peppol?

Yes, MEDICAB is registered on the Peppol network with ID 0208:0899779522.

What is the enterprise number of MEDICAB?

The enterprise number of MEDICAB is BE0899779522.

When was MEDICAB founded?

MEDICAB was founded on 13 August 2008.

Is MEDICAB a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 August 2008; 5 annual accounts filed, latest fiscal year 2025.

How much profit did MEDICAB make in 2025?

MEDICAB posted a profit after taxes of € 257,727 in financial year 2025.

What is the revenue of MEDICAB?

As a small company, MEDICAB is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 403,282.

MEDICAB (Private Limited) - Farciennes - BE0899779522

Dossier MEDICAB, printed on 31 October 2026 from databakkes.be/en/0899779522/medicab. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 38 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

MEDICAB from Farciennes, company number BE0899779522, closed financial year 2025 with a result of € 257,727 after tax. For that financial year MEDICAB recorded a gross margin of € 403,282 and equity of € 360,027. Compared with financial year 2024, the result moved from € 282,299 to € 257,727. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Healthy

€ 360,027

▼ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 257,727

▼ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 46,459

▼ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 339,319 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 51,756

▼ 21% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 90,744

▼ 17% vs 2024

€ 59,022 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Taxes

€ 46,043

▼ 28% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 361,199 Gross margin 2022: € 361,199 First fiscal year in the series	€ 361,265 Gross margin 2023: € 361,265 Unchanged (€ 361,199) Favourable step	€ 380,197 Gross margin 2024: € 380,197 ▲ 5% vs 2023 (€ 361,265) Favourable step	€ 403,282 Gross margin 2025: € 403,282 ▲ 6% vs 2024 (€ 380,197) Favourable step	▲ 6%
Profit after taxes	€ 274,482 Profit after taxes 2022: € 274,482 First fiscal year in the series	€ 269,354 Profit after taxes 2023: € 269,354 ▼ 2% vs 2022 (€ 274,482) Unfavourable step	€ 282,299 Profit after taxes 2024: € 282,299 ▲ 5% vs 2023 (€ 269,354) Favourable step	€ 257,727 Profit after taxes 2025: € 257,727 ▼ 9% vs 2024 (€ 282,299) Unfavourable step	▼ 9%
Equity	€ 709,645 Equity 2022: € 709,645 First fiscal year in the series	€ 502,418 Equity 2023: € 502,418 ▼ 29% vs 2022 (€ 709,645) Unfavourable step	€ 441,619 Equity 2024: € 441,619 ▼ 12% vs 2023 (€ 502,418) Unfavourable step	€ 360,027 Equity 2025: € 360,027 ▼ 18% vs 2024 (€ 441,619) Unfavourable step	▼ 18%
Total debts	€ 344,280 Total debts 2022: € 344,280 First fiscal year in the series	€ 436,093 Total debts 2023: € 436,093 ▲ 27% vs 2022 (€ 344,280) Unfavourable step	€ 489,859 Total debts 2024: € 489,859 ▲ 12% vs 2023 (€ 436,093) Unfavourable step	€ 455,835 Total debts 2025: € 455,835 ▼ 7% vs 2024 (€ 489,859) Favourable step	▼ 7%
Cash	€ 166,533 Cash 2022: € 166,533 First fiscal year in the series	€ 66,750 Cash 2023: € 66,750 ▼ 60% vs 2022 (€ 166,533) Unfavourable step	€ 57,931 Cash 2024: € 57,931 ▼ 13% vs 2023 (€ 66,750) Unfavourable step	€ 46,459 Cash 2025: € 46,459 ▼ 20% vs 2024 (€ 57,931) Unfavourable step	▼ 20%
Retained profit	€ 616,645 Retained profit 2022: € 616,645 First fiscal year in the series	€ 409,418 Retained profit 2023: € 409,418 ▼ 34% vs 2022 (€ 616,645) Unfavourable step	€ 348,619 Retained profit 2024: € 348,619 ▼ 15% vs 2023 (€ 409,418) Unfavourable step	€ 267,027 Retained profit 2025: € 267,027 ▼ 23% vs 2024 (€ 348,619) Unfavourable step	▼ 23%
Dividend	€ 274,482 Dividend 2022: € 274,482 First fiscal year in the series	€ 476,581 Dividend 2023: € 476,581 ▲ 74% vs 2022 (€ 274,482) Unchanged	€ 343,098 Dividend 2024: € 343,098 ▼ 28% vs 2023 (€ 476,581) Unchanged	€ 339,319 Dividend 2025: € 339,319 ▼ 1% vs 2024 (€ 343,098) Unchanged	▼ 1%
Bank debt	€ 64,219 Bank debt 2022: € 64,219 First fiscal year in the series	€ 51,053 Bank debt 2023: € 51,053 ▼ 21% vs 2022 (€ 64,219) Favourable step	€ 109,709 Bank debt 2024: € 109,709 ▲ 115% vs 2023 (€ 51,053) Unfavourable step	€ 90,744 Bank debt 2025: € 90,744 ▼ 17% vs 2024 (€ 109,709) Favourable step	▼ 17%
Balance sheet total	€ 1,053,924 Balance sheet total 2022: € 1,053,924 First fiscal year in the series	€ 938,511 Balance sheet total 2023: € 938,511 ▼ 11% vs 2022 (€ 1,053,924) Unchanged	€ 931,478 Balance sheet total 2024: € 931,478 ▼ 1% vs 2023 (€ 938,511) Unchanged	€ 815,862 Balance sheet total 2025: € 815,862 ▼ 12% vs 2024 (€ 931,478) Unchanged	▼ 12%

Key figures of MEDICAB, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDICAB?

What happened at MEDICAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: profit of € 257,727 (▼ 9% vs 2024). filed late Source: NBB ↗
Aug 13, 2008 New establishment in Farciennes. KBO
Aug 13, 2008 Start of the company according to the CBE. KBO

In short

From € 274,482 profit in 2022 to € 257,727 profit in 2025.

Paid € 408,392 in corporate taxes since 2022.

Best year ever: 2024, with € 282,299 profit.

Paid out € 1.4 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Bois(PIR) 18

6240 Farciennes

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0899.779.522
VAT number: BE 0899.779.522
Registered office: Rue du Bois(PIR) 18, 6240 Farciennes
Names & denominations: MEDICAB
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 August 2008
Peppol: Active · Active since 30 Dec 2024

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDICAB